141 related articles for article (PubMed ID: 29208367)
1. The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma.
Wen KC; Sung PL; Chou YT; Pan CM; Wang PH; Lee OK; Wu CW
Gynecol Oncol; 2018 Feb; 148(2):383-392. PubMed ID: 29208367
[TBL] [Abstract][Full Text] [Related]
2. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.
Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W
Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975
[TBL] [Abstract][Full Text] [Related]
3. MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.
Zhou N; Wang H; Liu H; Xue H; Lin F; Meng X; Liang A; Zhao Z; Liu Y; Qian H
J Exp Clin Cancer Res; 2015 Dec; 34():157. PubMed ID: 26698569
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated macrophage-derived CXCL8 could induce ERα suppression via HOXB13 in endometrial cancer.
Tong H; Ke JQ; Jiang FZ; Wang XJ; Wang FY; Li YR; Lu W; Wan XP
Cancer Lett; 2016 Jun; 376(1):127-36. PubMed ID: 27018308
[TBL] [Abstract][Full Text] [Related]
5. miR‑107‑5p promotes tumor proliferation and invasion by targeting estrogen receptor‑α in endometrial carcinoma.
Bao W; Zhang Y; Li S; Fan Q; Qiu M; Wang Y; Li Y; Ji X; Yang Y; Sang Z; Xu W; Yang Y; Wu S; Zhu Y
Oncol Rep; 2019 Mar; 41(3):1575-1585. PubMed ID: 30569100
[TBL] [Abstract][Full Text] [Related]
6. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
7. Enolase-1 is a therapeutic target in endometrial carcinoma.
Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.
Dellinger TH; Planutis K; Jandial DD; Eskander RN; Martinez ME; Zi X; Monk BJ; Holcombe RF
Gynecol Oncol; 2012 Aug; 126(2):259-67. PubMed ID: 22555103
[TBL] [Abstract][Full Text] [Related]
9. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor-associated kinase 1 correlates with metastasis and invasion in endometrial carcinoma.
Wang Y; Wang Y; Duan X; Wang Y; Zhang Z
J Cell Biochem; 2018 Mar; 119(3):2545-2555. PubMed ID: 28980703
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis.
Zeng L; Deng X; Zhong J; Yuan L; Tao X; Zhang S; Zeng Y; He G; Tan P; Tao Y
BMC Cancer; 2019 Aug; 19(1):831. PubMed ID: 31443698
[TBL] [Abstract][Full Text] [Related]
13. Forkhead-box A1 suppresses the progression of endometrial cancer via crosstalk with estrogen receptor α.
Wang J; Bao W; Qiu M; Liao Y; Che Q; Yang T; He X; Qiu H; Wan X
Oncol Rep; 2014 Mar; 31(3):1225-34. PubMed ID: 24452315
[TBL] [Abstract][Full Text] [Related]
14. The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.
Sun KX; Chen Y; Chen S; Liu BL; Feng MX; Zong ZH; Zhao Y
Oncotarget; 2016 Feb; 7(8):9236-49. PubMed ID: 26843615
[TBL] [Abstract][Full Text] [Related]
15. TMEFF2 is a novel prognosis signature and target for endometrial carcinoma.
Gao L; Nie X; Zheng M; Li X; Guo Q; Liu J; Liu Q; Hao Y; Lin B
Life Sci; 2020 Feb; 243():116910. PubMed ID: 31610211
[TBL] [Abstract][Full Text] [Related]
16. Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells.
Liang KH; Tso HC; Hung SH; Kuan II; Lai JK; Ke FY; Chuang YT; Liu IJ; Wang YP; Chen RH; Wu HC
Cancer Lett; 2018 Oct; 433():165-175. PubMed ID: 29981429
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
18. Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation.
van der Gun BTF; Wasserkort R; Monami A; Jeltsch A; Raskó T; Ślaska-Kiss K; Cortese R; Rots MG; de Leij LFMH; Ruiters MHJ; Kiss A; Weinhold E; McLaughlin PMJ
Int J Cancer; 2008 Jul; 123(2):484-489. PubMed ID: 18398839
[TBL] [Abstract][Full Text] [Related]
19. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
[TBL] [Abstract][Full Text] [Related]
20. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
